King Pharmaceuticals, Inc. (NYSE:KG)

CAPS Rating: 2 out of 5

The Company is a vertically integrated pharmaceutical company that develops, manufactures, markets and sells branded prescription pharmaceutical products.

Recs

0
Player Avatar JMartinBlack (45.91) Submitted: 4/17/2009 4:15:13 PM : Outperform Start Price: $8.84 KG Score: +5.05

King pharm has been performing well for me over the past month

Featured Broker Partners


Advertisement